Body composition characteristics and fat distribution patterns in young infertile women
|
|
- Todd O’Neal’
- 6 years ago
- Views:
Transcription
1 FERTILITY AND STERILITY VOL. 81, NO. 3, MARCH 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Body composition characteristics and fat distribution patterns in young infertile women Sylvia Kirchengast, a.o.univ.prof, a and Johannes Huber, o.univ.prof b University Clinic for Gynecology and Obstetrics, Department of Endocrinology, University of Vienna Medical School, Vienna, Austria Objective: To document body composition and fat patterning characteristics in normal and underweight infertile women. Design: Status quo method. Setting: University clinics. Patient(s): Fifteen amenorrheic women with anorexia nervosa, 16 women with polycystic ovary syndrome (PCO2), 10 women with primary amenorrhea and 19 healthy controls. Intervention(s): None. Main Outcome Measure(s): Determination of body mass index, body composition parameters such as fat mass, lean body mass, bone mass using dual-energy x-ray absorptiometry (DEXA), fat distribution patterns, 17 -estradiol, FSH, LH, prolactin, progesterone, testosterone, DHEA-S, and androstenedione levels. Result(s): A statistically significant difference was found comparing all proband groups with healthy controls for the majority of body fat and bone mineral content parameters but not for lean body mass. Infertile women of normal weight, with PCOS, and with primary amenorrhea exhibited an extraordinarily high amount of fat tissue and a tendency toward android fat patterning. In contrast, patients with anorexia nervosa and the healthy controls showed predominantly gynoid fat patterning. According to logistic regression analyses, anorexia nervosa was characterized by reduced fat tissue and PCOS was characterized by android fat patterning and an increased fat percentage. Patients with primary amenorrhea were characterized by reduced bone mass. Conclusion(s): Infertile young women showed characteristic differences in body composition and fat distribution patterns when compared with healthy, fertile, age-matched counterparts. (Fertil Steril 2004;81: by American Society for Reproductive Medicine.) Key Words: Infertility, body composition, weight status, fat distribution, PCOS, primary amenorrhea, anorexia nervosa Received January 9, 2003; revised and accepted August 22, Reprint requests: Sylvia Kirchengast, Institute for Anthropology, University of Vienna, Althanstrasse 14, A-1090 Vienna, Austria (FAX: ; sylvia.kirchengast@univie.ac.at). a Institute for Anthropology, University of Vienna, Vienna, Austria. b University Clinic for Gynecology and Obstetrics, Department of Endocrinology, University of Vienna Medical School, Vienna, Austria /04/$30.00 doi: /j.fertnstert Several epidemiological studies have emphasized the importance of body composition, especially of abdominal or android fat distribution patterns, as risk factors for cardiovascular and metabolic diseases such as diabetes mellitus (1, 2). It seems obvious that steroid hormones have effects on human adipose tissue metabolism and distribution (3, 4). In the female, body composition parameters and weight status are also clearly associated with reproductive function (5 9). The importance of body fat and energetics for female reproductive success was first pointed out during the 1970s Frisch (10), although the so-called Frisch hypothesis has since been disproved (11 13). Although the energy costs of human reproduction are lower than those of any other group of mammals (13), human ovarian function is extremely vulnerable to an energy imbalance (11). Pregnancy requires about 50,000 calories over and above normal metabolic requirements, and lactation requires from 500 to 1000 calories per day (14). Therefore, ovarian function shows a graded continuum from fully competent cycles through luteal phase suppression, follicular phase suppression, ovulatory failure, oligomenorrhea, or amenorrhea in response to endogenous and exogenous factors affecting energy balance (11). Just as a negative energy balance and low amount of body fat have a negative effect on human ovarian function, a 539
2 highly elevated amount of body fat and android kind of fat patterning also seem to affect female reproductive function negatively (6, 14, 15). Disturbed ovarian function seems to be associated with an extremely low or an extremely high amount of body fat and abdominal or android fat patterning, which is typical in healthy, postmenopausal women only (16). Furthermore, an android kind of fat patterning is associated with significantly decreased conception rates (17 19). In this way, body composition parameters as well as fat distribution patterns may be interpreted as extragenital markers of human ovarian function. The aim of the present study was to document body composition and fat patterning of young, infertile, normal weight women to test the hypothesis that body composition and fat distribution patterns are markers of potential female fertility. MATERIALS AND METHODS Study Participants The study enrolled 41 infertile Austrian women aged 18 to 30 years (x 23.5) and 19 healthy, age-matched controls (x 23.7). All controls had regular menstrual cycles (cycles of 26 to 33 days) and age-specific normal sex-hormone levels. Chromosomal aberrations such as Turner syndrome were excluded from the present sample. The sample of infertile young women was divided into three subgroups. Group 1 was 15 women (age range: 18 to 29 years) with secondary amenorrhea for more than 9 months as a result of low body weight from anorexia nervosa; all were extremely underweight but at the time of investigation their weight status was not life threatening. Group 2 consisted of 16 women (age range: 18 to 30 years) with PCOS, as diagnosed by ultrasound appearance of polycystic ovaries combined with hyperandrogenemia and elevated LH levels; all had secondary amenorrhea or oligomenorrhea. Group 3 comprised 10 women (age range: 18 to 30 years) who suffered from primary amenorrhea. None of the women suffering from primary amenorrhea had anatomic abnormalities; their primary amenorrhea was classified as idiopathic. Remarkably, 7 of the 10 women with primary amenorrhea had never sought medical treatment for the condition until their 20s. They reported that they had had no problems with their primary amenorrhea up to the time when they would have liked to become pregnant. Women who exhibited a body mass index (BMI) kg/m 2 were excluded from the present analyses. All women enrolled in the present study were white, underweight or normal weight, native Austrians. All lived in Vienna or neighboring Lower Austria and belonged to the social middle class. No data regarding education, professional training, profession, or place of residence were collected. None of the probands had ever been pregnant. All women were nonsmokers, and none of them were taking any medication that might affect hormone metabolism or body composition. Hormonal contraceptive usage had been stopped for a minimum of 4 months before the present investigation. Menstrual History Using a structured questionnaire, all probands were interviewed regarding their menstrual history. Data were collected on age at menarche, minimum and maximum cycle length, duration of amenorrhea, and use of hormonal medication. Protocol and Measurements Body Composition Analyses Body composition analyses and bone density analyses were performed using dual energy x-ray absorptiometry (DEXA) (Hologic 4000; Hologic, Inc., Waltham, MA) at the University Clinic for Gynecology and Obstetrics in Vienna (20). Although this method is indirect, its high reliability, relatively low cost, and greater comfort for the patients make DEXA especially useful for the determination of body composition. With this method, body composition consists of soft tissue (i.e., fat and lean soft tissue, and bone): DEXA measures total body bone mineral content (BMC) and density (BMD), and fat mass and lean mass with a precision (coefficient of variation) of 0.9%, 4.7%, and 1.5% respectively. The precision for abdominal fat mass and fat percentage (fat %) is 4.3% and 3.4%, respectively. The relatively low radiation dose with 0.1 m Sievert and short scanning time ( 7 minutes) make this technique especially suitable for such determinations. Scanning was done by the Hologic total body scanner. A phantom, especially constructed for body composition determination and calibrated for fat and lean mass and bone mineral content, was placed beside the patient. Default software readings provided lines positioned to divide the body into six compartments (i.e., head, trunk, arms, and legs). The trunk was defined by a horizontal line below the chin, and vertical lines passing through colli femuri. The region below this lower border of the trunk, including both legs and the hip region, is called the lower body region. For each region of the whole body, fat and lean body mass and BMC were determined. Fat Distribution Analysis For a better description of the sex typical fat distribution the fat distribution index (FDI) (21) was calculated: FDI Upper body fat mass (kg)/lower body fat mass (kg). An FDI below 0.9 indicates a gynoid fat patterning: the fat mass of the lower body surpasses the fat mass of the upper body. An FDI 1.1 defines an android fat distribution: the amount of upper body fat surpasses that of the lower body region. An FDI between 0.9 and 1.1 is defined as an intermediate stage of fat distribution. We are aware that the most widely used measure of fat distribution patterns is the waist-to-hip ratio. However, the waist-to-hip ratio describes actual body shape and body 540 Kirchengast and Huber Body composition and infertility Vol. 81, No. 3, March 2004
3 TABLE 1 Comparison of hormonal levels Kruskal-Wallis tests. Hormone Primary amenorrhea Anorexia nervosa PCOS Controls X (SD) X (SD) X (SD) X (SD) P value E 2 (pg/ml) 37.9 (36.1) 16.0 (7.3) (33.94) 78.4 (46.0).004 FSH (mu/ml) 2.98 (3.27) 5.65 (1.69) 5.17 (2.15) 6.80 (2.05).005 LH (mu/ml) 2.02 (3.69) 1.83 (2.60) 5.97 (5.11) 7.47 (4.32).007 HPRL (ng/ml) (13.88) (8.79) (17.16) 9.80 (3.05) NS P (ng/ml) 0.94 (2.19) 0.40 (0.13) 1.37 (1.64) 1.23 (1.91) NS T (ng/ml) 0.19 (1.11) 0.36 (0.20) 0.58 (0.37) 0.32 (0.11).004 A (ng/ml) 1.99 (0.74) 2.44 (0.89) 3.01 (1.62) 1.99 (0.59) NS DHEA-S ( g/ml) 1.80 (1.11) 1.68 (0.66) 2.31 (1.01) 1.82 (0.42).05 GH (ng/ml) 2.89 (3.83) 2.56 (2.06) 0.98 (0.37) 2.68 (3.18) NS TSH ( U/mL) 2.15 (1.17) 1.55 (0.80) 1.46 (1.14) 1.44 (0.74) NS Kirchengast. Body composition and infertility. Fertil Steril silhouette but not the quantitative amount of fat distribution. Furthermore, we are aware that the FDI describes not the ratio of abdominal fat to gluteofemoral fat but the ratio between upper body fat, including abdominal fat and breast fat mass, and lower body fat. Weight Status After stature (in cm) and body weight (in kg) had been calculated according to previously published methods (22), the individual s weight status was determined by means of body mass index (BMI): Weight (kg)/stature (m 2 ). World Health Organization (23) criteria were used for the weight status classification: Thinness grade 1: BMI (mild thinness) Thinness grade 2: BMI (moderate thinness) Thinness grade 3: BMI (severe thinness) Normal range: BMI Overweight grade 1: BMI (overweight) Overweight grade 2: BMI (obese 1) Overweight grade 3: BMI (obese 2) Hormonal Parameters Blood samples for the quantitative determination of hormone levels were collected between 7.30 AM and 9.30 AM before the 10th day of cycle (in menstruating women). The quantitative determination was made at the central hormone laboratory of the University Clinic for Gynecology and Obstetrics. After coagulation, the samples were centrifuged and the serum was stored at 20 C until further processing. Assays were employed according to NCCLS guidelines as follows (intra-assay and interassay CV in parentheses): The following hormones were determined: 17 -estradiol (5.2%; 8.5%) (Autodelfia; Wallac Oy, Turku, Finland), follicle-stimulating hormone (FSH) (4.2%; 8.3%) (Enzymun ES700; Böhringer Mannheim, Mannheim, Germany); luteinizing hormone (LH) (9.3%; 3.9%) (Autodelfia; Wallac Oy), prolactin (4.7%; 8.5%) (Enzymun; Böhringer Mannheim), progesterone (6.4%; 10.0%) by radioimmunoassay (Coat-A- Coat RIA; DPC, Los Angeles, CA), testosterone (6.5%, 11.2%), dehydroepiandrostendionsulfate (DHEA-S) (7.4%; 10.5%) by radioimmunoassay (Immunotech, Westbrook, ME); and androstenedione (6.6%; 9.0%) by radioimmunoassay (Immunotech, Westbrook, ME). Statistical Analyses Statistical analyses were performed by means of SPSS Version 10.0 (SPSS, Inc., Chicago, IL). After computing descriptive statistics (mean, standard deviation, median, range), Kruskal-Wallis tests were calculated to group differences with respect to their statistical significance. Because of the low number of patients and the results of the Kolmogorov-Smirnov test, which indicated that no normal distribution of the data could be assumed, nonparametric tests were applied predominantly. Chi-squares were computed to test group differences with respect to categorical variables. Binary logistic regression analyses were performed to test the association of body composition, weight status, and fat patterning with ovarian function (proband group). RESULTS Comparison of Hormone Levels In the first step of analyses, the sex-hormone levels of the four groups were compared. The four groups differed significantly in estradiol, FSH, LH, testosterone, and DHEA-S levels. As expected, PCOS patients exhibited the highest androgen levels and women with primary amenorrhea and anorexia nervosa showed lower estrogen, gonadotropin, and progesterone levels than PCOS patients and healthy controls (Table 1). Comparison of Body Composition and Fat Distribution Patterns Although only the normal weight and underweight women were included in the present analyses, the four FERTILITY & STERILITY 541
4 TABLE 2 Comparison of body composition parameters Kruskal-Wallis tests. Variable Primary amenorrhea Anorexia nervosa PCOS Controls X (SD) X (SD) X (SD) X (SD) P value Fat head (kg) 0.8 (0.1) 0.7 (0.0) 0.8 (0.1) 0.8 (0.1) NS Fat trunk (kg) 6.2 (2.7) 3.1 (1.6) 14.1 (7.5) 5.5 (2.4).0001 Fat arm (kg) 1.1 (0.4) 0.5 (0.2) 1.3 (0.5) 0.9 (0.4).0001 Fat leg left (kg) 3.8 (1.2) 2.5 (0.7) 4.6 (0.9) 3.9 (1.0).0001 Fat leg right (kg) 3.8 (1.2) 2.6 (0.8) 4.7 (1.1) 3.9 (0.9).0001 Fat total (kg) 16.7 (5.6) 10.2 (3.2) 21.7 (5.6) 16.1 (4.8).0001 Lean head (kg) 2.9 (0.3) 2.9 (0.2) 3.1 (0.3) 2.9 (0.2) NS Lean trunk (kg) 18.5 (2.3) 19.9 (1.8) 18.8 (2.5) 20.6 (2.0) NS Lean arm (kg) 2.1 (0.5) 1.8 (0.4) 1.5 (0.4) 2.0 (0.5).02 Lean leg left (kg) 6.2 (1.3) 5.9 (0.8) 5.5 (0.6) 6.4 (1.2) NS Lean leg right (kg) 6.3 (1.5) 6.2 (0.9) 5.6 (0.8) 6.6 (1.8) NS Lean total (kg) 37.9 (6.4) 37.7 (2.8) 35.4 (3.7) 40.4 (4.8) NS BMC head (g) (14.4) (77.6) (67.4) (79.4).006 BMC trunk (g) (718.8) (78.9) (0.99.2) (101.7).01 BMC arm (g) (23.0) (22.1) (14.9) (23.8).01 BMC leg left (g) (69.6) (57.3) (60.6) (56.0).04 BMC leg right (g) (64.9) (57.5) (65.8) (67.5).01 BMC total (g) (256.5) (233.1) (276.7) (245.2).008 Fat % head 20.2 (0.2) 17.1 (2.1) 17.4 (1.0) 18.3 (2.7).002 Fat % trunk 23.8 (7.6) 12.7 (6.1) 31.8 (10.4) 20.2 (5.9).0001 Fat % arm 31.9 (6.8) 22.5 (9.8) 43.3 (10.1) 31.6 (11.9).001 Fat % leg left 36.5 (6.4) 28.3 (6.5) 42.9 (6.3) 36.1 (5.1).0001 Fat % leg right 36.5 (7.2) 28.2 (7.1) 41.8 (6.9) 35.6 (5.1).0001 Fat % total 29.2 (5.7) 19.9 (5.5) 35.7 (7.6) 27.1 (4.4).0001 Stature (cm) (9.9) (4.5) (5.1) (5.7) NS Body weight (kg) 56.6 (11.9) 49.9 (4.9) 57.8 (3.9) 58.6 (9.1).001 BMI (kg/m 2 ) (3.4) (1.49) (1.42) (2.37).0001 FDI 0.81 (0.27) 0.58 (0.22) 1.03 (0.23) 0.70 (0.19).003 Kirchengast. Body composition and infertility. Fertil Steril groups differed significantly regarding weight status ( df 6; P. 003). None of the PCOS patients was underweight; this was also true of 16.7% of the controls, 73.5% of the anorexia nervosa patients, and 40% of the women with primary amenorrhea. Regarding body composition parameters, the three groups of infertile women and the healthy controls showed a highly statistically significant difference in nearly all body fat and bone mineral content parameters but not in lean body mass, with the exception of the lean mass of the arm (Table 2). Although overweight women were excluded from the present analyses, women with PCOS exhibited not only an extraordinarily high amount of absolute and relative fat tissue in comparison with the anorexia nervosa patients, women with primary amenorrhea, and healthy controls, but they also showed a tendency toward android fat distribution patterns. The fat distribution patterns of nearly 70% of the women with PCOS and 40% of those with primary amenorrhea were classified as intermediate or android. In contrast, about 80% of anorexia nervosa patients and the healthy controls showed a typically gynoid kind of fat patterning; none of them exhibited an android fat distribution. The group differences regarding fat distribution patterns were statistically highly significant ( , P.003, df 6). According to the results of the logistic regression analyses, anorexia nervosa patients were characterized by a significantly reduced fat mass (coefficient 0.54, P.01); PCOS patients, in comparison with healthy controls, are especially characterized by a high fat distribution index (coefficient 4.63, P.01), indicating android fat patterning and increased fat percentage (coefficient 0.19 P.05). Primary amenorrhea was most of all related to a reduced bone mass in comparison with healthy controls (coefficient 0.03, P.05). DISCUSSION Female reproductive function has been known to be associated with body composition characteristics for a long time. It is well known that female reproductive function is extremely vulnerable to energy imbalance and changes in energy storage (11, 24). A reduction of metabolic fuel availability below a critical level by food restriction or increased 542 Kirchengast and Huber Body composition and infertility Vol. 81, No. 3, March 2004
5 expenditure is appropriately accompanied by activation of multiple neuroendocrine changes, resulting in anovulation and amenorrhea (25). In particular, body fat, which is the most important compartment for the body s energy storage, influences ovarian function in different ways (24). The conversion from androgens to estrogens by aromatization takes place at the adipose tissue; nearly a third of circulating estrogens in women during reproductive phase stem from this conversion. Body fat influences the direction of estrogen metabolism to more potent or less potent forms; leaner women with a reduced amount of body fat show higher levels of less potent forms of estrogens, such as catechol estrogens. High amounts of body fat seem to be associated with reduced capacity to bind sex hormone-binding globulin; thus, an elevated percentage of free serum estradiol is found in obese and overweight women. Adipose tissue also can store steroid hormones; an indirect mechanism may be providing signals to the hypothalamus of abnormal control of temperature and changes in energy metabolism that accompany excessive leanness in women. Finally, a high amount of fat tissue, especially in combination with abdominal fat patterning, is associated with supranormal estrogen production due to increased activity of the aromatase system (6). Obesity and abdominal fat patterning are associated with hyperandrogenism, mostly found in women suffering from PCOS (7, 26, 27). Several studies had yielded an association between fat distribution patterns and reproductive function or reproductive success. Our study compared body composition parameters and fat distribution patterns of three groups of young women with ovarian failure. For measuring fat distribution patterns, we decided to use the fat distribution index rather than the waist-to-hip ratio (WHR). We are aware that WHR is frequently used to describe female body shape, but we wanted to estimate the quantitative ratio of upper to lower body fat, not simply describe the body silhouette. Although the majority of women suffering from PCOS are overweight, we included exclusively normal weight or underweight women in the present analysis to improve comparability of the data. Anorexia nervosa, PCOS, and primary amenorrhea have completely different etiologies and hormonal characteristics, but we could demonstrate that in all three forms of ovarian failure the body composition parameters and fat distribution patterns seem to be related to the disturbed ovarian function. Anorexia nervosa is characterized by restricted food consumption and a long-time negative energy balance (28 30). Therefore, the extremely low amount of body fat we found among our anorectic patients was expected. This decreased amount of fat tissue leads to a long-term negative energy balance and a suppression of ovarian function, although women may recover and ovarian function may normalize again. The typical gynoid fat patterning of anorexia nervosa may indicate the potential possibility of reproductive success after a time of nutritional surplus (31). In contrast, the prognosis for PCOS is worse. Although we excluded overweight women from the present analyses, the PCOS women exhibited the significantly highest amount of body fat; 50% of the women showed an android kind of fat patterning. This prevailing android fat patterning is not only in clear contradiction to standards of female attractiveness in 90% of investigated cultures (32, 33), it is also strongly associated with hyperandrogenism (6, 7, 26) and markedly decreased conception rates (17 19). In healthy women, android fat patterning is found nearly exclusively during the postmenopause period, the postreproductive phase of female life (16). Even the results of the binary logistic regression analyses demonstrated that PCOS women were characterized by an increased fat percentage and an increased fat distribution index, indicating a tendency toward android fat patterning. Furthermore, a decreased amount of lean body mass was found among the PCOS patients, which is in sharp contrast to the increased androgen levels found among this group. Because androgens act anabolically, an increased lean body mass might be assumed; however, the PCOS women of the present study exhibited the lowest amount of lean body mass at all anatomical regions among all of the study groups. The women with primary amenorrhea exhibited a slightly increased amount of body fat in comparison with healthy controls and anorectic patients. In contrast, their bone mineral content was significantly decreased. This may be due to the long-term decrease in sex-hormone levels. These young women actually never experienced the hormonal changes of puberty inducing menarche. The importance of sex steroids in the development and maintenance of the skeleton in women is unquestioned. Estrogen deficiency at any age is associated with negative skeletal effects (34). The low levels of sex steroids in this group may be the reason for their reduced bone mass. Reduced bone mass is not a visible marker of infertility, so we must consider the fat distribution patterns of women with primary amenorrhea. Although only underweight and normal weight women were included in the analyses, 20% of the infertile probands in our sample exhibited android fat patterning, and 80% exhibited a gynoid or an intermediate kind of fat patterning. In contrast, none of the healthy controls showed android fat distribution patterns. Although 20% is not a very high percentage, our sample size was rather small. Thus, body composition and fat distribution may be interpreted as extragenital markers of ovarian failure with the direction of association depending on the cause of ovarian failure. References 1. Björntorp P. The associations between obesity, adipose tissue and disease. Acta Med Scand 1988;723: Björntorp P. Obesity. Lancet 1997;350: FERTILITY & STERILITY 543
6 3. Rebuffe-Scrive M, Brönnegard M, Nilson A, Eldh J, Gustafson JA, Björntorp P. Steroid hormone receptors in human adipose tissue. J Endocrinol Metab 1990;71: Hollmann M, Runnebaum B, Gerhard I. Impact of waist to hip ratio and body mass index on hormonal and metabolic parameters in young, obese women. Int J Obstet Rel Metab Disord 1997;21: Grodstein F, Goldman MB, Cramer DW. Body mass and ovulatory infertility. Epidemiology 1994;5: Diamanti-Kandarakis E, Bergiele A. The influence of obesity on hyperandrogenism and infertility in the female. Obstet Rev 2001;2: Moran C, Hernandez E, Ruiz JE, Fonseca ME, Bermudez JA, Zarate A. Upper body obesity and hyperinsulinemia are associated with anovulation. Gynecol Obstet Invest 1999;47: Norman RJ, Clark AM. Obesity and reproductive disorders: a review. Reprod Fertil Dev 1998;10: Rich-Edwards JW, Goldman MB, Willett WC, Hunter DJ, Stampfer MJ, Colditz GA, Manson JE. Adolescent body mass index and infertility caused by ovulatory disorder. Am J Obstet Gynecol 1994;171: Frisch R. Population, food intake and fertility. Science 1978;199: Ellison PT. Human ovarian function and reproductive ecology. Am Anthropol 1990;2: Ellison PT. Advances in human reproductive ecology. Ann Rev Anthropol 1994;23: Prentice AM, Whitehead RG. The energetic of human reproduction. Symp Zool Soc Lond 1987;57: Lovejoy JC. The influence of sex hormones on obesity across the female life span. J Wom Health 1998;7: Strowitzki T, Halser B, Demant T. Body fat distribution, insulin sensitivity, ovarian dysfunction and serum lipoproteins in patients with polycystic ovary syndrome. Gynecol Endocrinol 2002;16: Kirchengast S, Gruber D, Sator M, Hartmann B, Knogler W, Huber J. Menopause associated differences in female fat patterning estimated by dual energy x-ray absorptiometry. Ann Hum Biol 1997;24: Zaadstra BM, Seidell JC, Van Noord PA, te Velde ER, Habbema JD, Vrieswijk B, Karbaat J. Fat and female fecundity: prospective study of effect of body fat distribution on conception rates. BMJ 1993;306: Wass P, Waldenström U, Rössner S, Hellberg D. An android body fat distribution in females impairs the pregnancy rate of in-vitro fertilization-embryo transfer. Hum Reprod 1997;12: Jenkins JM, Brook PF, Sargeant S, Cooke ID. Endocervical mucus ph is inversely related to serum androgen levels and waist to hip ratio. Fertil Steril 1995;63: Blake GM, Fogelman I. Technical principles of dual energy x-ray absorptiometry. Semin Nucl Med 1997;27: Kirchengast S, Gruber D, Sator M, Knogler W, Huber J. The fat distribution index a new possibility to quantify sex specific fat patterning in females. Homo 1997;48: Knussmann R. Somatometrie. In: Knussmann R, ed. Anthropologie. Stuttgart: Fischer Verlag, World Health Organization. Physical status: the use and interpretation of anthropometry. [Tech Rep Series 854.] Geneva: World Health Organization, Frisch R. The right weight: body fat, menarche and fertility. Nutrition 1996;12: Yen SS. Effects of lifestyle and body composition on the ovary. Endocrinol Metab Clin N Am 1998;27: Moran C, Knochenbauer E, Boots LR, Azziz R. Adrenal androgen excess in hyperandrogenism: relation to age and body mass. Fertil Steril 1999;71: Kirchengast S, Huber J. Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Hum Reprod 2001;16: Bale P, Doust J, Dawson D. Gymnasts, distance runners, anorexics body composition and menstrual status. J Sport Med Phys Fitness 1996;36: Couzinet B, Young J, Brailly S, Le Bouc Y, Chanson P, Schaison G. Functional hypothalamic amenorrhea: a partial and reversible gonadotrophin deficiency of nutritional origin. Clin Endocrinol 1999;50: Kerruish KP, O Connor J, Humphries IR, Kohn MR, Clarke SD, Briody JN, et al. Body composition in adolescents with anorexia nervosa. Am J Clin Nutr 2002;75: Kirchengast S, Huber J. Fat distribution patterns in young amenorrhoeic females. Hum Nat 2001;12: Brown PJ. Culture and evolution of human obesity. Hum Nat 1991;2: Singh D. Ideal female body shape: role of body weight and waist-to-hip ratio. Int J Eating Disord 1994;16: Väänänen HK, Härkönen PL. Estrogen and bone metabolism. Maturitas 1996;71: Kirchengast and Huber Body composition and infertility Vol. 81, No. 3, March 2004
Reproductive outcome in women with body weight disturbances
Reproductive outcome in women with body weight disturbances Zeev Shoham M.D. Dep. Of OB/GYN Kaplan Hospital, Rehovot, Israel Weight Status BMI (kg/m 2 ) Underweight
More informationS. AMH in PCOS Research Insights beyond a Diagnostic Marker
S. AMH in PCOS Research Insights beyond a Diagnostic Marker Dr. Anushree D. Patil, MD. DGO Scientist - D National Institute for Research in Reproductive Health (Indian Council of Medical Research) (Dr.
More informationOverview of Reproductive Endocrinology
Overview of Reproductive Endocrinology I have no conflicts of interest to report. Maria Yialamas, MD Female Hypothalamic--Gonadal Axis 15 4 Hormone Secretion in the Normal Menstrual Cycle LH FSH E2, Progesterone,
More informationReproductive FSH. Analyte Information
Reproductive FSH Analyte Information 1 Follicle-stimulating hormone Introduction Follicle-stimulating hormone (FSH, also known as follitropin) is a glycoprotein hormone secreted by the anterior pituitary
More informationWEIGHT GAIN DURING MENOPAUSE EMERGING RESEARCH
MENOPAUSE WHEN DOES IT OCCUR? The cessation of the menstrual cycle for one year. WEIGHT GAIN DURING MENOPAUSE EMERGING RESEARCH Jan Schroeder, Ph.D. Chair of The Department of Kinesiology California State
More informationROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU)
ROLE OF HORMONAL ASSAY IN DIAGNOSING PCOD DR GAANA SREENIVAS (JSS,MYSURU) In 1935, Stein and Leventhal described 7 women with bilateral enlarged PCO, amenorrhea or irregular menses, infertility and masculinizing
More informationAchieving Pregnancy: Obesity and Infertility. Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center
Achieving Pregnancy: Obesity and Infertility Jordan Vaughan, MSN, APN, WHNP-BC Women s Health Nurse Practitioner Nashville Fertility Center Disclosures Speakers Bureau EMD Serono Board of Directors Nurse
More informationPolycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018
Polycystic Ovary Syndrome HEATHER BURKS, MD OU PHYSICIANS REPRODUCTIVE MEDICINE SEPTEMBER 21, 2018 Learning Objectives At the conclusion of this lecture, learners should: 1) Know the various diagnostic
More informationThe study of correlation between BMI and infertility. Dr. seyed mohammadreza fouladi
The study of correlation between BMI and infertility Dr. seyed mohammadreza fouladi Female Infertility Infertility is a generally defined as one year unprotected intercourse without contraception. Approximately
More informationclinical outcome and hormone profiles before and after laparoscopic electroincision of the ovaries in women with polycystic ovary syndrome
& clinical outcome and hormone profiles before and after laparoscopic electroincision of the ovaries in women with polycystic ovary syndrome Zulfo Godinjak¹*, Ranka Javorić² 1 Gynecology and Obstetrics
More informationWHY NEW DIAGNOSTIC CRITERIA FOR DIFFERENT PCOS PHENOTYPES ARE URGENTLY NEEDED
WHY NEW DIAGNOSTIC CRITERIA FOR DIFFERENT PCOS PHENOTYPES ARE URGENTLY NEEDED Ricardo Azziz, M.D., M.P.H., M.B.A. Chief Officer of Academic Health & Hospital Affairs State University of New York (SUNY)
More informationWEIGHT CHANGE AND ANDROGEN LEVELS DURING CONTRACEPTIVE TREATMENT OF WOMEN AFFECTED BY POLYCYSTIC OVARY
ENDOCRINE REGULATIONS, VOL. 40, 119-123, 2006 119 WEIGHT CHANGE AND ANDROGEN LEVELS DURING CONTRACEPTIVE TREATMENT OF WOMEN AFFECTED BY POLYCYSTIC OVARY J. VRBIKOVA, K. DVORAKOVA, M. HILL, L. STARKA Institute
More informationMETABOLIC RISK MARKERS IN WOMEN WITH POLYCYSTIC OVARIAN MORPHOLOGY
Vuk Vrhovac University Clinic Dugi dol 4a, HR-10000 Zagreb, Croatia Original Research Article Received: February 18, 2010 Accepted: March 3, 2010 METABOLIC RISK MARKERS IN WOMEN WITH POLYCYSTIC OVARIAN
More informationDr Stella Milsom. Endocrinologist Fertility Associates Auckland. 12:30-12:40 When Puberty is PCO
Dr Stella Milsom Endocrinologist Fertility Associates Auckland 12:30-12:40 When Puberty is PCO Puberty or Polycystic Ovary Syndrome? Stella Milsom Endocrinologist Auckland DHB, University of Auckland,
More informationPolycystic Ovarian Syndrome (PCOS) LOGO
Polycystic Ovarian Syndrome (PCOS) Ma qianhong Ob/Gyn Department LOGO Contents Epidemiology and Definition Pathophysiology, Endocrinological Features Diagnostic Criteria Treatment Prognosis Introduction
More informationDetermining the insulin resistance rate in Polycystic Ovary Syndrome patients (PCOs)
Abstract: Determining the insulin resistance rate in Polycystic Ovary Syndrome patients (PCOs) Ashraf Olabi, Ghena Alqotini College of medicine, Aleppo University Hospital Obstetrics and Gynacology, Syria.
More informationIMPACT OF NUTRITION ON GYNECOLOGICAL HEALTH OF FEMALE ADOLESCENTS
IMPACT OF NUTRITION ON GYNECOLOGICAL HEALTH OF FEMALE ADOLESCENTS Kedikova S. MD, PhD Medical University Sofia, Bulgaria University Hospital Maichin dom Sofia NUTRITION WHO - Nutrition is the intake of
More informationCase Questions. Polycystic Ovarian Syndrome: Treatment Goals and Options. Differential Diagnosis of Hyperandrogenic Anovulation
Polycystic Ovarian Syndrome: Treatment Goals and Options Marc Cornier, MD Division of Endocrinology, Metabolism and Diabetes Colorado Center for Health and Wellness University of Colorado School of Medicine
More information12/13/2017. Important references for PCOS. Polycystic Ovarian Syndrome (PCOS) for the Family Physician. 35 year old obese woman
Polycystic Ovarian Syndrome (PCOS) for the Family Physician Barbara S. Apgar MD, MS Professor or Family Medicine University of Michigan Ann Arbor, Michigan Important references for PCOS Endocrine Society
More informationPrevalence of Anovulation in Subfertile Women in Kerbala 2012, A descriptive Cross-Sectional Study
Prevalence of Anovulation in Subfertile Women in Kerbala 2012, A descriptive Cross-Sectional Study Mousa Mohsen Ali* Wasan Ghazi* HayderAamerAbboud^ *Kerbala University, College of Medicine, Gynecology
More informationClinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes
POLYCYSTIC OVARY SYNDROME Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes Ettore Guastella, M.D., a Rosa Alba Longo, M.D., b and Enrico Carmina, M.D. b a Department
More informationSAMPLE REPORT. Order Number: PATIENT. Age: 40 Sex: F MRN:
Patient: Age: 40 Sex: F MRN: SAMPLE PATIENT Order Number: Completed: Received: Collected: SAMPLE REPORT Progesterone ng/ml 0.34 0.95 21.00 DHEA-S mcg/dl Testosterone ng/ml 48 35 0.10 0.54 0.80 430 Sex
More informationRelationship between bone resorption and adrenal sex steroids and their derivatives in oophorectomized women
FERTILITY AND STERILITY VOL. 82, NO. 6, DECEMBER 2004 Copyright 2004 American Society for Reproductive Medicine Published by Elsevier Inc. Printed on acid-free paper in U.S.A. Relationship between bone
More informationMetabolic changes in menopausal transition
Metabolic changes in menopausal transition Terhi T. Piltonen M.D., Associate Professor Consultant, Clinical Researcher for the Finnish Medical Foundation Department of Obstetrics and Gynecology PEDEGO
More informationEffect of troglitazone on endocrine and ovulatory performance in women with insulin resistance related polycystic ovary syndrome
FERTILITY AND STERILITY VOL. 71, NO. 2, FEBRUARY 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Effect of troglitazone
More informationHormone. Free Androgen Index. 2-Hydroxyestrone. Reference Range. Hormone. Estrone Ratio. Free Androgen Index
Hormonal Health PATIENT: Sample Report TEST REF: TST-12345 Hormonal Health 0.61 0.30-1.13 ng/ml DHEA-S 91 35-430 mcg/dl tient: SAMPLE TIENT e: x: N: Sex Binding Globulin 80 18-114 nmol/l Testosterone 0.34
More informationCASE 41. What is the pathophysiologic cause of her amenorrhea? Which cells in the ovary secrete estrogen?
CASE 41 A 19-year-old woman presents to her gynecologist with complaints of not having had a period for 6 months. She reports having normal periods since menarche at age 12. She denies sexual activity,
More informationInfertility for the Primary Care Provider
Infertility for the Primary Care Provider David A. Forstein, DO FACOOG Clinical Associate Professor Obstetrics and Gynecology University of South Carolina School of Medicine Greenville Disclosure I have
More informationThe Bone Wellness Centre - Specialists in DEXA Scanning 855 Broadview Avenue Suite # 305 Toronto, Ontario M4K 3Z1
Birth Date: 40.2 years Height / Weight: 158.0 cm 52.0 kg Sex / Ethnic: Female Patient ID: Total Body Tissue Quantitation Composition Reference: Total Tissue 50% 40% 30% 20% 20 30 40 50 60 70 80 90 100
More informationNitasha Garg 1 Harkiran Kaur Khaira. About the Author
https://doi.org/10.1007/s13224-017-1082-4 ORIGINAL ARTICLE A Comparative Study on Quantitative Assessment of Blood Flow and Vascularization in Polycystic Ovary Syndrome Patients and Normal Women Using
More informationNew PCOS guidelines: What s relevant to general practice
New PCOS guidelines: What s relevant to general practice Dr Michael Costello Fertility Specialist IVF Australia UNSW Royal Hospital for Women Sydney How do we know if something is new? Louvre Museum, Paris
More informationAs the health benefits of exercise are increasingly
Effects of Lifetime Exercise on the Outcome of In Vitro Fertilization Stephanie N. Morris, MD, Stacey A. Missmer, ScD, Daniel W. Cramer, MD, R. Douglas Powers, MD, Patricia M. McShane, MD, and Mark D.
More informationThe Bone Wellness Centre - Specialists in Dexa Scanning 855 Broadview Avenue Suite # 305 Toronto, Ontario M4K 3Z1
Birth Date: 24.7 years Height / Weight: 8.0 cm 79.0 kg Sex / Ethnic: Male Patient ID: Total Body Tissue Quantitation Composition Reference: Total Tissue 40% 30% 20% 0% 20 30 40 50 60 70 80 90 00 Centile
More informationPolycystic Ovary Syndrome
Polycystic Ovary Syndrome Definition: the diagnostic criteria Evidence of hyperandrogenism, biochemical &/or clinical (hirsutism, acne & male pattern baldness). Ovulatory dysfunction; amenorrhoea; oligomenorrhoea
More informationThe Bone Wellness Centre - Specialists in DEXA Scanning 855 Broadview Avenue Suite # 305 Toronto, Ontario M4K 3Z1
The Bone Wellness Centre - Specialists in DEXA Scanning 855 Broadview Avenue Suite # 305 Toronto, Ontario M4K 3Z1 Patient: Birth Date: 48.2 years Height / Weight: 150.0 cm 72.0 kg Sex / Ethnic: Female
More informationThe Bone Wellness Centre - Specialists in DEXA Scanning 855 Broadview Avenue Suite # 305 Toronto, Ontario M4K 3Z1
The Bone Wellness Centre - Specialists in DEXA Scanning 855 Broadview Avenue Suite # 305 Toronto, Ontario M4K 3Z1 Patient: Birth Date: 43.4 years Height / Weight: 170.0 cm 66.0 kg Sex / Ethnic: Female
More informationRole of inositol in Reproductive Function
Role of inositol in Reproductive Function Dr. Mirudhubashini Govindarajan, FRCSC Clinical Director Womens Center Coimbatore HYPE OR HOPE???? Inositol an Introduction Inositol has 10 types of isomers Myo
More informationAbnormal Uterine Bleeding Case Studies
Case Study 1 Abnormal Uterine Bleeding Case Studies Abigail, a 24 year old female, presents to your office complaining that her menstrual cycles have become a problem. They are now lasting 6 7 days instead
More informationRelationship between Energy Expenditure Related Factors and Oxidative Stress in Follicular Fluid
Original Article Relationship between Energy Expenditure Related Factors and Oxidative Stress in Follicular Fluid Abstract This study evaluated the impact of body mass index (BMI), total calorie intake
More informationPolycystic Ovary Disease: A Common Endocrine Disorder in Women
Polycystic Ovary Disease: A Common Endocrine Disorder in Women Paul Kaplan, M.D. Clinical Professor of Reproductive Endocrinology - OHSU Courtesy Senior Research Associate, Human Physiology University
More informationPolycystic Ovary Syndrome (PCOS):
Polycystic Ovary Syndrome (PCOS): Current diagnosis and treatment Anatte E. Karmon, MD Disclosures- Anatte Karmon, MD No financial relationships to disclose 2 Objectives At the end of this presentation,
More informationUnderstanding Body Composition
Understanding Body Composition Chapter 7 Body Composition n Body composition is the ratio between fat and fat-free mass n Fat-free mass includes all tissues exclusive of fat (muscle, bone, organs, fluids)
More informationInvestigation of adrenal functions in patients with idiopathic hyperandrogenemia
European Journal of Endocrinology (26) 155 37 311 ISSN 84-4643 CLINICAL STUDY Investigation of adrenal functions in patients with idiopathic hyperandrogenemia Hulusi Atmaca, Fatih Tanriverdi 1, Kursad
More informationEndocrinology of the Female Reproductive Axis
Endocrinology of the Female Reproductive Axis girlontheriver.com Geralyn Lambert-Messerlian, PhD, FACB Professor Women and Infants Hospital Alpert Medical School at Brown University Women & Infants BROWN
More informationTHE PREVALENCE AND ETIOLOGY OF POLYCYSTIC OVARIAN SYNDROME (PCOS) AS A CAUSE OF FEMALE INFERTILITY IN CENTRAL TRAVANCORE
NSave Nature to Survive 9(1): 01-06, 2014 www.thebioscan.in THE PREVALENCE AND ETIOLOGY OF POLYCYSTIC OVARIAN SYNDROME (PCOS) AS A CAUSE OF FEMALE INFERTILITY IN CENTRAL TRAVANCORE K. ROY GEORGE AND N.
More informationThe Egyptian Journal of Hospital Medicine (January 2019) Vol. 74 (1), Page 63-69
The Egyptian Journal of Hospital Medicine (January 2019) Vol. 74 (1), Page 63-69 Effect of Metformin Only versus Effect of Metformin and Corticosteroids after Laparoscopic Ovarian Drilling on Ovulation
More informationReproductive physiology
Reproductive physiology Sex hormones: Androgens Estrogens Gestagens Learning objectives 86 (also 90) Sex Genetic sex Gonadal sex Phenotypic sex XY - XX chromosomes testes - ovaries external features Tha
More informationMetformin Therapy Decreases Hyperandrogenism and Ovarian Volume in Women with Polycystic Ovary Syndrome
IJMS Vol 36, No 2, June 2011 Original Article Metformin Therapy Decreases Hyperandrogenism and Ovarian Volume in Women with Polycystic Ovary Syndrome Marzieh Farimani Sanoee 1, Nosrat Neghab 1, Soghra
More informationObesity is a risk factor for early pregnancy loss after IVF or ICSI
Acta Obstet Gynecol Scand 2000; 79: 43 48 Copyright C Acta Obstet Gynecol Scand 2000 Printed in Denmark All rights reserved Acta Obstetricia et Gynecologica Scandinavica ISSN 0001-6349 ORIGINAL ARTICLE
More informationX/06/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 91(1):2 6 Copyright 2006 by The Endocrine Society doi: /jc.
0021-972X/06/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 91(1):2 6 Printed in U.S.A. Copyright 2006 by The Endocrine Society doi: 10.1210/jc.2005-1457 EXTENSIVE CLINICAL EXPERIENCE Relative
More informationHormone Balance - Female Report SAMPLE. result graph based on Luteal Phase. result graph based on Luteal Phase
Patient Name: Patient DOB: Gender: Physician: Test Hormone Balance - Female Report SAMPLE Grote, Mary Jane Batch Number: B6437 2/16/1954 Accession Number: N52281 F Date Received: 2/3/2015 Any Lab Test
More informationEffect of Body Mass Index on IVF Procedure and Outcome
ORIGINAL STUDY Effect of Body Mass Index on IVF Procedure and Outcome Al Marzooqi T. Obstetrics and Gynecology Department, Women's Hospital, Hamad Medical Corporation, Doha, Qatar Declaration of interests:
More informationLONG OR HIGHLY IRREGULAR MENstrual
ORIGINAL CONTRIBUTION Long or Highly Irregular Menstrual Cycles as a Marker for Risk of Type 2 Diabetes Mellitus Caren G. Solomon, MD Frank B. Hu, MD Andrea Dunaif, MD Janet Rich-Edwards, DSci Walter C.
More information16 YEAR-OLD OBESE FEMALE WITH OLIGOMENORRHEA
16 YEAR-OLD OBESE FEMALE WITH OLIGOMENORRHEA Katie O Sullivan, MD Adult/Pediatric Endocrinology Fellow University of Chicago ENDORAMA Thursday, September 4th, 2014 Disclosures No financial interests. Will
More informationDUAL ENERGY X-RAY ABSORPTIOMETRY (DXA) GOLD STANDARD FOR BONE HEALTH AND BODY COMPOSITION ASSESSMENT
DUAL ENERGY X-RAY ABSORPTIOMETRY (DXA) GOLD STANDARD FOR BONE HEALTH AND BODY COMPOSITION ASSESSMENT Prof d-r Slavica Šubeska Stratrova Clinic of Endocrinology, Skopje, Macedonia Definition and classification
More informationEvidence tables from the systematic literature search for premature ovarian insufficiency surveillance in female CAYA cancer survivors.
Evidence tables from the systematic literature search for premature ovarian insufficiency surveillance in female CAYA cancer survivors. Who needs surveillance? Chiarelli et al. Early menopause and Infertility
More informationValidation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome
Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome Madelon van Wely, Ph.D., a Bart C. J. M. Fauser, M.D., Ph.D., b Joop S. E. Laven,
More informationRelation of luteinizing hormone levels to body mass index in premenopausal women
FERTILITY AND STERILITY VOL. 69, NO. 3, MARCH 1998 Copyright 1998 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Relation of luteinizing
More informationSelection criteria of normal controls to predict reliable cut-off values of various endocrine parameters in infertility
J Obstet Gynecol India Vol. 55, No. 1 : January/February 2005 Pg 72-76 ORIGINAL ARTICLE The Journal of Obstetrics and Gynecology of India Selection criteria of normal controls to predict reliable cut-off
More informationToo much of a good thing
Too much of a good thing The Female Athlete Triad: Toward improved screening and management Asma Javed Pediatric and Adolescent Gynecology Mayo Clinic, Rochester Disclosure No relevant financial disclosure
More informationDOES INSULIN RESISTANCE CAUSE HYPERANDROGENEMIA OR HYPERANDROGENEMIA CAUSES INSULIN RESISTANCE IN PCOS
DOES INSULIN RESISTANCE CAUSE HYPERANDROGENEMIA OR HYPERANDROGENEMIA CAUSES INSULIN RESISTANCE IN PCOS D R. G A N A P A T H I. B D E P T. O F E N D O C R I N O L O G Y S T. J O H N S M E D I C A L C O
More informationThe prevalence of polycystic ovary syndrome in Iranian women based on different diagnostic criteria
Prace oryginalne/original papers Endokrynologia Polska/Polish Journal of Endocrinology Tom/Volume 62; Numer/Number 3/2011 ISSN 0423 104X The prevalence of polycystic ovary syndrome in Iranian women based
More informationObjectives 06/21/18 STILL A PLACE FOR PILLS DON T IVF EVERYTHING. Clomiphene citrate and Letrozole. Infertility Case Studies. Unexplained Infertility
STILL A PLACE FOR PILLS DON T IVF EVERYTHING Jeff Roberts M.D. Co-Director, Pacific Centre for Reproductive Medicine Objectives 1 2 3 4 5 Clomiphene citrate and Letrozole Infertility Case Studies Unexplained
More informationIs semen quality affected by male body fat distribution?
ORIGINAL ARTICLE Is semen quality affected by male body fat distribution? I. Fejes, S. Koloszár, J. Szöll}osi, Z. Závaczki & A. Pál Department of Obstetrics and Gynaecology, Faculty of Medicine, University
More informationInfluence of body mass index and age on the grade of hair growth in hirsute women of reproductive ages*
FERTILITY AND STERILITY Copyright 1988 The American Fertility Society Vol. 50, No. 2, August 1988 Printed in U.S.A. Influence of body mass index and age on the grade of hair growth in hirsute women of
More informationReproductive Health and Pituitary Disease
Reproductive Health and Pituitary Disease Janet F. McLaren, MD Assistant Professor Division of Reproductive Endocrinology and Infertility Department of Obstetrics and Gynecology jmclaren@uabmc.edu Objectives
More informationThe contributions of oestrogen and growth factors to increased adrenal androgen secretion in polycystic ovary syndrome
Human Reproduction vol.14 no.2 pp.307 311, 1999 The contributions of oestrogen and growth factors to increased adrenal androgen secretion in polycystic ovary syndrome E.Carmina 1, F.Gonzalez 2, A.Vidali
More informationReproductive hormones and epilepsy
3 rd Congress of the European Academy of Neurology Amsterdam, The Netherlands, June 24 27, 2017 Teaching Course 7 Treatment of women with epilepsy - Level 1-2 Reproductive hormones and epilepsy Gerhard
More informationManagement of Obesity in Postmenopausal Women
Management of Obesity in Postmenopausal Women Yong Seong Kim, M.D. Division of Endocrinology and Metabolism Inha University College of Medicine & Hospital E mail : yongskim@inha.ac.kr Abstract Women have
More informationInfertility Treatment in Polycystic Ovary Syndrome: Lifestyle Interventions, Medications and Surgery
Macut D, Pfeifer M, Yildiz BO, Diamanti-Kandarakis E (eds): Polycystic Ovary Syndrome. Novel Insights into Causes Infertility Treatment in Polycystic Ovary Syndrome: Lifestyle Interventions, Medications
More informationPrevalence of Polycystic Ovarian Syndrome among urban adolescent girls and young women in Mumbai
Prevalence of Polycystic Ovarian Syndrome among urban adolescent girls and young women in Mumbai Principal Investigator Co- Investigators Consultant Collaborating Hospital Dr. Beena Joshi Dr. Srabani Mukherji
More informationBody composition: A predictive factor of cycle fecundity
ORIGINAL ARTICLE pissn 2233-8233 eissn 2233-8241 Clin Exp Reprod Med 2014;41(2):75-79 Body composition: A predictive factor of cycle fecundity Semra Kayatas, Aysen Boza, Murat Api, Didar Kurt, Mustafa
More informationPolycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks
Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks Kate D. Schoyer, M.D. May 6, 2016 Objectives To review how to make the diagnosis of Polycystic Ovarian Syndrome (PCOS)
More informationThe menstrual cycle. François Pralong
The menstrual cycle François Pralong Services d Endocrinologie, Diabétologie et Métabolisme, Hôpitaux Universitaires de Genève et Lausanne Centre des Maladies CardioVasculaires et Métaboliques, Lausanne
More informationRisk of Developing Polycystic Ovarian Syndrome- Adolescent Girls
Open Access Journal Research Article DOI: 1.98/ijirms/vol-i/ Risk of Developing Polycystic Ovarian Syndrome- Adolescent Girls Satyajit Assistant Professor, Shri Guru Ram Dass College of Nursing, Hoshiarpur
More informationHyperandrogenism. Dr Jack Biko. MB. BCh (Wits), MMED O & G (Pret), FCOG (SA), Dip Advanced Endoscopic Surgery(Kiel, Germany)
Hyperandrogenism Dr Jack Biko MB. BCh (Wits), MMED O & G (Pret), FCOG (SA), Dip Advanced Endoscopic Surgery(Kiel, Germany) 2012 Hyperandrogenism Excessive production of androgens Adrenal glands main source
More informationINSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME An Overview
INSULIN RESISTANCE, POLYCYSTIC OVARIAN SYNDROME An Overview University of PNG School of Medicine & Health Sciences Division of Basic Medical Sciences PBL MBBS III VJ Temple 1 Insulin Resistance: What is
More informationPolycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks. Kate D. Schoyer, M.D. May 6, 2016
Polycystic Ovarian Syndrome: Diagnosis, Preconceptional Management and Health Risks Kate D. Schoyer, M.D. May 6, 2016 Objectives To review how to make the diagnosis of Polycystic Ovarian Syndrome (PCOS)
More informationGonadotrophin treatment in patients with Polycystic Ovary Syndrome
Int. J. Adv. Res. Biol. Sci. (218). 5(4): 95-99 International Journal of Advanced Research in Biological Sciences ISSN: 2348-869 www.ijarbs.com DOI: 1.22192/ijarbs Coden: IJARQG(USA) Volume 5, Issue 4-218
More informationYour environment: Your fertility
Your environment: Your fertility Strong Fertility Center Education Series September 25, 2008 Shanna H. Swan, PhD Professor Obstetrics & Gynecology University of Rochester School of Medicine Has fertility
More informationPERIMENOPAUSE. Objectives. Disclosure. The Perimenopause Perimenopause Menopause. Definitions of Menopausal Transition: STRAW.
PERIMENOPAUSE Patricia J. Sulak, MD Founder, Living WELL Aware LLC Author, Should I Fire My Doctor? Author, Living WELL Aware: Eleven Essential Elements to Health and Happiness Endowed Professor Texas
More informationStudy of clinical presentation in cases of Polycystic Ovarian Syndrome in rural population
Original article: Study of clinical presentation in cases of Polycystic Ovarian Syndrome in rural population 1Dr Shalini Kanotra, 2 Dr Nikita Singh*, 3 Dr V B Bangal 1 Associate Professor, OBGY Department,
More informationAction of reproductive hormones through the life span 9/22/99
Action of reproductive hormones through the life span Do reproductive hormones affect the life span? One hypothesis about the rate of aging asserts that there is selective pressure for either high rate
More informationPCOS and Obesity DUB is better treated by OCPs
PCOS and Obesity DUB is better treated by OCPs Dr. Ritu Joshi Senior consultant Fortis escorts Hospital, Jaipur Chairperson Family welfare com. FOGSI (20092012) Vice President FOGSI 2014 Introduction One
More informationThe Bone Wellness Centre - Specialists in Dexa Total Body 855 Broadview Avenue Suite # 305 Toronto, Ontario M4K 3Z1
Patient: Obese, Sample Birth Date: 0/Jan/966 44.4 years Height / Weight: 72.0 cm 95.0 kg Sex / Ethnic: Male Patient ID: Referring Physician: DR. SMITH Measured: 07/Jun/200 7:0:52 PM (.40) Analyzed: 02/Apr/203
More informationClinical correlation with biochemical status in polycystic ovarian syndrome
J Obstet Gynecol India Vol. 55, No. 1 : January/February 2005 Pg 67-71 ORIGINAL ARTICLE The Journal of Obstetrics and Gynecology of India Clinical correlation with biochemical status in polycystic ovarian
More informationClinical Study Hyperandrogenism Does Not Influence Metabolic Parameters in Adolescent Girls with PCOS
International Endocrinology Volume 2012, Article ID 434830, 5 pages doi:10.1155/2012/434830 Clinical Study Hyperandrogenism Does Not Influence Metabolic Parameters in Adolescent Girls with PCOS Kim Forrester-Dumont,
More informationPituitary desensitization to gonadotropinreleasing hormone increases abdominal adiposity in hyperandrogenic anovulatory women
FERTILITY AND STERILITY VOL. 70, NO. 1, JULY 1998 Copyright 1998 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Pituitary desensitization
More informationWhat every dermatologist should know about Polycystic Ovary Syndrome (PCOS)
What every dermatologist should know about Polycystic Ovary Syndrome (PCOS) Kanade Shinkai, MD PhD University of California, San Francisco Associate Professor of Dermatology I have no conflicts of interest
More informationROLE OF METFORMIN IN POLYCYSTIC OVARIAN SYNDROME
ORIGINAL ARTICLE ROLE OF METFORMIN IN POLYCYSTIC OVARIAN SYNDROME 1 2 3 Samdana Wahab, Farnaz, Rukhsana Karim ABSTRACT Objective: To assess the role of Metformin in Polycystic ovarian syndrome (PCOS).
More informationTitle: Studying the Complex Relationships Between Physical Activity and Infertility
Title: Studying the Complex Relationships Between Physical Activity and Infertility Authors: Kelly R. Evenson, PhD, MS Department of Epidemiology, Gillings School of Global Public Health, University of
More informationDaily blood hormone levels related to the luteinizing hormone surge in anovulatory cycles
FRTILITY AND STRILITY Copyright 1983 The American Fertility Society Printed in U.8A. Daily blood hormone levels related to the luteinizing hormone surge in anovulatory cycles Chung H. Wu, M.D. * F. Susan
More informationGONADAL, ADRENAL, ANDROGEN AND THYROID FUNCTIONS IN ADULTS TREATED FOR ACUTE LYMPHOBLASTIC LEUKEMIA
original paper Haematologica 1994; 79:141-147 GONADAL, ADRENAL, ANDROGEN AND THYROID FUNCTIONS IN ADULTS TREATED FOR ACUTE LYMPHOBLASTIC LEUKEMIA Fiorina Giona*, Luciana Annino*, Paola Donato, Michele
More informationBone mineral density and body composition in lean women with polycystic ovary syndrome
FERTILITY AND STERILITY VOL. 72, NO. 1, JULY 1999 Copyright 1999 American Society for Reproductive Medicine Published by Elsevier Science Inc. Printed on acid-free paper in U.S.A. Bone mineral density
More informationDiagnostic Performance of Serum Total Testosterone for Japanese Patients with Polycystic Ovary Syndrome
Endocrine Journal 2007, 54 (2), 233 238 Diagnostic Performance of Serum Total Testosterone for Japanese Patients with Polycystic Ovary Syndrome TAKESHI IWASA, TOSHIYA MATSUZAKI, MASAHIRO MINAKUCHI, NAOKO
More informationPCOS guidelines: What s relevant to general practice
PCOS guidelines: What s relevant to general Dr David Molloy Medical Director, Queensland Fertility Group International evidence based PCOS guidelines 1st ever internationally endorsed & evidence based
More informationThe menstrual Cycle. François Pralong
The menstrual Cycle François Pralong Services d Endocrinologie, Diabétologie et Métabolisme, Hôpitaux Universitaires de Genève et Lausanne Centre des Maladies CardioVasculaires et Métaboliques, Lausanne
More informationJMSCR Vol 05 Issue 05 Page May 2017
www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i5.14 Hyperinsulinemia in Polycystic Ovary Syndrome
More informationCynthia Morris DO, FACOOG, FACOS Medical Director, Women s Wellness Center Fayette County Memorial Hospital
Cynthia Morris DO, FACOOG, FACOS Medical Director, Women s Wellness Center Fayette County Memorial Hospital Touchdown to CME Eighth District Academy of Osteopathic Medicine & Surgery October 8. 2017 Goals
More informationClinical Manifestations of the Polycystic Ovary Syndrome at Menopausal Age
American Journal of Medicine and Medical Sciences 2019, 9(1): 35-39 DOI: 10.5923/j.ajmms.20190901.06 Clinical Manifestations of the Polycystic Ovary Syndrome at Menopausal Age Gafurova F. A. Assistant
More information